Summary & Overview
HCPCS C8919: Magnetic Resonance Angiography, Pelvis, No Contrast
HCPCS Level II code C8919 denotes magnetic resonance angiography (MRA) of the pelvis performed without intravenous contrast. This non-contrast vascular imaging study is used to evaluate pelvic arterial and venous anatomy and pathology when contrast administration is contraindicated or unnecessary. Nationally, non-contrast MRA is relevant for vascular assessment, postoperative surveillance, and evaluation of suspected vascular lesions while avoiding contrast-related risks.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise overview of clinical context for non-contrast pelvic MRA, typical sites of service, and the role of C8919 within imaging service lines. The publication outlines benchmarking and coverage considerations used by major payers, common billing practices for technical and professional components, and policy updates that affect when non-contrast MRA is billed versus contrast-enhanced studies.
The material explains how C8919 is applied in clinical workflows, typical documentation elements that support medical necessity, and how this code integrates with related imaging and vascular service lines. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code C8919 represents magnetic resonance angiography without contrast of the pelvis. The service is an imaging study that uses magnetic resonance technology to evaluate pelvic blood vessels without the use of intravenous contrast agents. The service type is diagnostic imaging (magnetic resonance angiography, non-contrast). The typical site of service is hospital outpatient imaging center or freestanding outpatient radiology clinic, where MR scanners and vascular imaging protocols for pelvic studies are available.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with progressive claudication and known peripheral arterial disease is referred for vascular imaging to evaluate pelvic and proximal lower extremity arterial anatomy. The patient has chronic kidney disease stage 3, limiting use of iodinated or gadolinium-based contrast agents. The ordering vascular surgeon requests a non-contrast vascular study to assess arterial stenosis, occlusion, or aneurysm in the pelvis prior to planning revascularization.
The clinical workflow: the referring clinician orders C8919 (magnetic resonance angiography without contrast, pelvis). The patient arrives at the outpatient imaging center or hospital radiology department (typical sites of service include outpatient hospital radiology suite or freestanding imaging center). Intake includes verification of indications, screening for MRI safety (implants, pacemaker, ferromagnetic material), and renal status to confirm contrast avoidance. A certified MRI technologist performs the non-contrast MRA protocol of the pelvis using time-of-flight or phase-contrast and arterial spin labeling techniques. The study is interpreted by a board-certified diagnostic radiologist or vascular radiologist, with a finalized report documenting arterial anatomy, presence/degree of stenosis or occlusion, and recommendations for correlation with clinical findings. Technical component billing may be separated from the professional interpretation when applicable using appropriate modifiers and TC and 26 components as needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|